Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Aran B. Merati"'
Autor:
Dhananjaya Pal, Guillermo A. Morales, Alok R. Singh, Tatiana G. Kutateladze, Adam M. Burgoyne, Kendra R. Vann, Donald L. Durden, Francisco M. Vega, Shweta Joshi, Aran B. Merati
Publikováno v:
Cell Discovery
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
The PI3K-AKT-mTOR pathway has been at the center of anti-cancer drug development1,2, but targeted inhibition of PI3K kinase activity is proven to provide a limited therapeutic effect and is often followed by the development of resistance to the drug3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7908c1a6f1c38b97a92dc063ea2aa725
http://hdl.handle.net/10261/238737
http://hdl.handle.net/10261/238737
Autor:
Steven L. Gonias, Karra A. Jones, Andrew S. Gilder, Na Du, Michael A. Banki, Scott R. VandenBerg, Donald P. Pizzo, Michael S. Lam, Aran B. Merati
Publikováno v:
Neuro-oncology, vol 18, iss 5
Author(s): Jones, Karra A; Gilder, Andrew S; Lam, Michael S; Du, Na; Banki, Michael A; Merati, Aran; Pizzo, Donald P; VandenBerg, Scott R; Gonias, Steven L | Abstract: BackgroundIn glioblastoma (GBM), the gene for epidermal growth factor receptor (EG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d1a69ff0800fe077fee54c06298470
https://doi.org/10.1093/neuonc/nov243
https://doi.org/10.1093/neuonc/nov243
